Health and Fitness Health and Fitness
Wed, August 11, 2010
[ Wed, Aug 11th 2010 ] - Market Wire
Protox reports Second Quarter 2010 financial results
[ Wed, Aug 11th 2010 ] - Market Wire
MannKind Receives Commitment to Purchase Up to 18,200,000 Shares of Common Stock for Cash
[ Wed, Aug 11th 2010 ] - Market Wire
MannKind Receives Commitment from The Mann Group .. eturn for Up to 18,200,000 Shares of Common Stock
[ Wed, Aug 11th 2010 ] - Market Wire
Valeant and Biovail Set Date for Shareholders Meetings
[ Wed, Aug 11th 2010 ] - Market Wire
Genoptix Announces Participation at 2010 Southern California Investor Conference
Tue, August 10, 2010
[ Tue, Aug 10th 2010 ] - Market Wire
Elan Corporation Plc Announces Intent to Offer US .. e Principal Amount of 8.75% Senior Notes Due 2016
[ Tue, Aug 10th 2010 ] - Market Wire
Molina Healthcare Announces Pricing of Common Stock Offering
[ Tue, Aug 10th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. of Shareholders of SciClone Pharmaceuticals, Inc.
[ Tue, Aug 10th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. lf of Shareholders of Penwest Pharmaceuticals Co.
[ Tue, Aug 10th 2010 ] - Market Wire
Levi & Korsinsky, LLP Investigates SciClone Pharmaceuticals, Inc.
[ Tue, Aug 10th 2010 ] - Market Wire
Hi-Tech Pharmacal to Present at the Bank of America 2010 Specialty Pharmaceuticals Conference
[ Tue, Aug 10th 2010 ] - Market Wire
Roy Jacobs & Associates Investigating SciClone Ph .. . for Possible Securities Law Violations ("SCLN")
[ Tue, Aug 10th 2010 ] - Market Wire
Cardiome to Release Second Quarter Results
[ Tue, Aug 10th 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Webcast of its P .. e Canaccord Genuity 30th Annual Growth Conference
[ Tue, Aug 10th 2010 ] - Market Wire
Inhibitex to Present at the Canaccord Genuity 30t .. Annual Growth Conference on Thursday, August 12th
[ Tue, Aug 10th 2010 ] - Market Wire
BioMimetic Therapeutics, Inc. to Present at the Canaccord Genuity Global Growth Conference
[ Tue, Aug 10th 2010 ] - Market Wire
Cubist Pharmaceuticals and the New England Patrio .. Program to Recognize Innovative Science Teachers
[ Tue, Aug 10th 2010 ] - Market Wire
Aetna Appoints Wayne Rawlins, M.D., to New Role Addressing Disparities in Health Care
[ Tue, Aug 10th 2010 ] - Market Wire
Synovis Life Technologies to Webcast Fiscal Third .. arter Earnings Conference Call Wednesday, Aug. 25
[ Tue, Aug 10th 2010 ] - Market Wire
Kahn Swick & Foti, LLC and Former Attorney Genera .. tigation Into SciClone Pharmaceuticals, Inc. - SC
[ Tue, Aug 10th 2010 ] - Market Wire
American Learning Corporation Reports First Quarter Results
[ Tue, Aug 10th 2010 ] - Market Wire
Odyssey HealthCare Stockholders Approve Proposed Acquisition by Gentiva Health Services
[ Tue, Aug 10th 2010 ] - Market Wire
Wellstar Establishes Data Storage for Images
[ Tue, Aug 10th 2010 ] - Market Wire
Positron Announces Opening of cGMP Manufacturing Facility
[ Tue, Aug 10th 2010 ] - Market Wire
Prestige Brands Adds Little Fevers(R) to Its Little Remedies(R) Line of Pediatric OTCs
[ Tue, Aug 10th 2010 ] - Market Wire
American Bio Medica Corporation Second Quarter 2010 Conference Call and Webcast
[ Tue, Aug 10th 2010 ] - Market Wire
Labopharm announces U.S. launch of OLEPTRO(TM) fo .. treatment of major depressive disorder in adults
[ Tue, Aug 10th 2010 ] - Market Wire
Spectral Molecular Imaging, Inc. to Develop a New .. Imaging Endoscopes Based on Optical Technology fr
[ Tue, Aug 10th 2010 ] - Market Wire
Columbia Laboratories Repurchases 3.3 Million Shares of Common Stock
[ Tue, Aug 10th 2010 ] - Market Wire
Micromet to Present at the Canaccord Genuity 30th Annual Growth Conference

Micromet to Present at the Canaccord Genuity 30th Annual Growth Conference


Published on 2010-08-10 05:10:56 - Market Wire
  Print publication without navigation


BETHESDA, Md.--([ BUSINESS WIRE ])--Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, announced today that the Company will participate in the Canaccord Genuity 30th Annual Growth Conference, to be held on August 11, 2010 in Boston. Members of the Companya™s management team will present a 25 minute corporate overview on August 11 at 2:30 PM ET.

The presentation will be webcast live and may be accessed by visiting the Micromet website at [ www.micromet.com ]. A replay of the webcast will also be available on the Company's website.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including Bayer Schering Pharma, Boehringer Ingelheim, MedImmune, Merck Serono, Nycomed and sanofi-aventis. Additional information can be found at [ www.micromet.com ].

Contributing Sources